Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's Lymphoma (HL)”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Testing effectiveness (Phase 2)Study completedNCT00481871
What this trial is testing

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Who this might be right for
Relapsed or Refractory Lymphoproliferative MalignanciesHodgkin's LymphomaPeripheral T-cell Lymphoma+2 more
Acrotech Biopharma Inc. 119
Testing effectiveness (Phase 2)Study completedNCT01874054
What this trial is testing

Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Seagen Inc. 55
Testing effectiveness (Phase 2)UnknownNCT04888741
What this trial is testing

Methods of T Cell Depletion Trial (MoTD)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelomonocytic Leukemia+6 more
University of Birmingham 400
Not applicableEnded earlyNCT00879528
What this trial is testing

Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or Refractory

Who this might be right for
Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS 264
Testing effectiveness (Phase 2)Study completedNCT02298283
What this trial is testing

Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD

Who this might be right for
Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 40
Not applicableLooking for participantsNCT05100056
What this trial is testing

Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma
Takeda 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03712202
What this trial is testing

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage I Hodgkin LymphomaAnn Arbor Stage I Mixed Cellularity Classic Hodgkin LymphomaAnn Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma+11 more
City of Hope Medical Center 155
Testing effectiveness (Phase 2)Looking for participantsNCT06090864
What this trial is testing

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Who this might be right for
Hodgkin LymphomaRelapseRefractory
UNC Lineberger Comprehensive Cancer Center 31
Not applicableStudy completedNCT01478191
What this trial is testing

Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCT

Who this might be right for
Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS 495
Testing effectiveness (Phase 2)UnknownNCT02098512
What this trial is testing

Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients

Who this might be right for
Hodgkin Lymphoma
New York Medical College 20
Not applicableStudy completedNCT01578967
What this trial is testing

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, Adult
UNC Lineberger Comprehensive Cancer Center 41
Early research (Phase 1)Active Not RecruitingNCT03150329
What this trial is testing

Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.

Who this might be right for
Grade 3b Follicular LymphomaRecurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HLRecurrent Classic Hodgkin Lymphoma+13 more
City of Hope Medical Center 52
Testing effectiveness (Phase 2)Study completedNCT00061672
What this trial is testing

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHodgkin's Lymphoma
Abbott 67
Testing effectiveness (Phase 2)Study completedNCT02065154
What this trial is testing

Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome+3 more
University of Alabama at Birmingham 39
Not applicableStudy completedNCT07145125
What this trial is testing

Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2)

Who this might be right for
Relapsed or Refractory Hodgkin Lymphoma
University Hospital, Bordeaux 222
Testing effectiveness (Phase 2)Active Not RecruitingNCT03576378
What this trial is testing

BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

Who this might be right for
Hodgkin Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 41
Testing effectiveness (Phase 2)Ended earlyNCT05883449
What this trial is testing

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPeripheral T Cell Lymphoma
Affimed GmbH 25
Not applicableStudy completedNCT01820117
What this trial is testing

Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

Who this might be right for
Hodgkin Lymphoma
St. Jude Children's Research Hospital 416
Testing effectiveness (Phase 2)Ended earlyNCT01964755
What this trial is testing

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

Who this might be right for
Epstein Barr Virus Associated Non Hodgkin's LymphomaEpstein Barr Virus Associated Hodgkin's LymphomaPost-Transplant Lymphoproliferative Disease
University of Miami 6
Early research (Phase 1)Looking for participantsNCT05272384
What this trial is testing

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Hodgkin Lymphoma+3 more
National Cancer Institute (NCI) 32
Load More Results